GlobalCompliancePanel

Device firms, establishments or facilities that are involved in the production and distribution of medical devices intended for use in the U.S are required to register annually.

Medical devices are classified into three classes, Class I, II, and III, based on the level of control necessary to assure the safety and effectiveness of the device.Recalls of Class II devices represent 61% of all device recalls over a review period

Promoting a drug or device for a use not approved by the Food and Drug Administration is illegal. As a result of this practice, called "off-label promotion,"

This web seminar has been designed to provide you with a clear understanding of project management skills to apply to running clinical trials.

There is a pervasive public perception that the FDA has been ineffective in protecting the public. Recent news events seem to support this perception. The FDA is working hard to change that perception.

Expectations for meaningful hazard analysis, hazardous conditions, and documentation have always existed by regulatory agencies.

There is a pervasive public perception that the FDA has been ineffective in protecting the public.

There is an on-going major shift in the emphasis of U.S. FDA cGMP compliance audits. These changes in focus have a major impact on individual compliance objectives, efforts and measurements of success.

This three hour overview of investment risk will provide the fundamentals to market, portfolio, and credit risk management that all investors, and those in financial services need to comprehend.

This webinar helps you understand the FDA device regulations related to Excel spreadsheets.